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How the immune system adapts to malnutrition to sustain immunity at barrier surfaces, such as the intestine, remains unclear. Vitamin A deficiency is one of the most common micronutrient deficiencies and is associated with profound defects in adaptive immunity. Here, we found that type 3 innate lymphoid cells (ILC3s) are severely diminished in vitamin A-deficient settings, which results in compromised immunity to acute bacterial infection. However, vitamin A deprivation paradoxically resulted in dramatic expansion of interleukin-13 (IL-13)-producing ILC2s and resistance to nematode infection in mice, which revealed that ILCs are primary sensors of dietary stress. Further, these data indicate that, during malnutrition, a switch to innate type 2 immunity may represent a powerful adaptation of the immune system to promote host survival in the face of ongoing barrier challenges.
M aintenance of barrier defense is an absolute requirement for mammalian host health and survival. Intestinal immunity has evolved in the context of constitutive exposure to microbial pressures. In this regard, the gastrointestinal (GI) tract is home to an estimated 100 trillion commensals, and more than 2 billion humans are chronically infected with parasitic worms (1, 2) . Over the course of evolution, maintenance of barrier immunity had to adapt to unstable nutritional availability in the face of these ongoing challenges. Although dietary ligands can be sensed by immune cells (3) (4) (5) (6) , it is not clear how the immune system integrates dietary cues in order to tune immune responses on the basis of the nutritional state of the host.
Malnutrition remains the primary cause of immunosuppression worldwide (7) . Nonetheless, despite profoundly impaired adaptive immunity associated with malnutrition, most humans can survive for extended periods of severe dietary restriction. We postulated that compensatory mechanisms might be in place to sustain defined branches of immunity and, in particular, responses associated with the protection of barrier tissues. Vitamin A deficiency is one of the most common nutrient deficiencies, affecting an estimated 250 million children in regions of the world where chronic worm infections are prevalent (8) . This essential micronutrient supports adaptive immunity through its metabolite, retinoic acid (RA), which is highly enriched in the gastrointestinal tract (9, 10) . Here, we examine the possibility that innate lymphoid cells (ILCs)-potent mediators of barrier maintenance, tissue repair, and host defense (11, 12) -may be primary sensors of dietary stress able to sustain barrier defense in the context of vitamin A deficiency.
Several subsets of ILCs have been described, with two dominant tissue-resident populations (12) . At steady state, retinoic acid receptor (RAR)-related orphan receptor gamma (RORgt + ILCs) (ILC3s) are dominantly present in the gut, whereas the majority of ILCs residing in the lung or skin belong to the GATA3 + ILC2 subset (11, 13, 14) (Fig. 1, A and B) . We explored the possibility that vitamin A metabolites may act as a local cue to control ILC populations. As previously described, T helper cells, T H 1 and T H 17 (15, 16) , as well as T H 2 cells, were significantly reduced in the gut of vitamin A-deficient (VAI) mice ( fig. S1, A and B) . The number of gut resident ILCs, ILC1s, and lymphoid tissue inducer cells (LTi's) remained unchanged in VAI mice ( fig. S2, A to D) . However, ILC3s and ILCderived IL-22 and IL-17 were greatly reduced in VAI wild-type (WT) and Rag1 -/-mice ( Fig. 1 , C to H, and figs. S3 and S4). Impaired cytokine expression was associated with reduced expression of RORgt ( fig. S4B ). In contrast, we observed a significant increase in ILC2-and ILC-derived IL-13, IL-5, and IL-4 in the gut of VAI mice (Fig. 1 , F, G, and H, and fig. S5, A and B).
Acute inhibition of RA signaling with the pan-RAR inhibitor BMS493 (RAi) (17) also resulted in reduced ILC3s and ILC-derived IL-22 and inversely increased ILC2s and ILC-derived IL-13 in both WT and Rag1 -/-mice ( Fig. 1, I and J, and fig. S6 , A to D). Alterations in ILC subsets subsequent to RA deprivation occurred independently of commensals ( fig. S7 ). Short-term treatment of VAI Rag1 -/-mice with RA restored ILC3 frequencies and cytokine production to levels found in control mice and reduced ILC2 numbers (Fig. 2, A to C) . VAI Rag1 -/-mice or mice treated with RAi displayed lower frequencies of Ki67-expressing ILC3s than control mice, whereas the number of Ki67-expressing ILC2s was greatly increased (Fig. 2, D and E) . Conversely, addition of RA reversed the proliferative potential of ILCs to frequencies observed in control mice (Fig. 2D) . Thus, RA acts as a switch to control a proliferative balance between the two intestinal ILC subsets.
To address whether RA signaling influenced the fate of ILCs, we transferred common lymphoid progenitors (CLPs) to mice devoid of ILCs (Rag2 (12) . Transferred CLPs gave rise to both ILC2s and ILC3s that accumulated in the GI tract (18, 19) (Fig. 2, F and G) . Exogenous delivery of RA led to a dominant accumulation of ILC3s in the intestine, whereas inhibition of RA signaling favored ILC2 accumulation (Fig. 2, F and G). Both ILC2s and ILC3s selectively express the nuclear receptor RARa (20) (fig. S8 ). We retrovirally transfected progenitors with lymphoid potential obtained from mice carrying WT www.sciencemag.org SCIENCE VOL 343 24 JANUARY 2014 gave rise to ILC2s (Fig. 2H) . Further, addition of RA impaired ILC2 development from ILC2 progenitors (ILC2Ps), whereas inhibition of RA signaling resulted in increased ILC2 accumulation and IL-13 production in culture (Fig. 2I ). These results reveal a cell-intrinsic suppressive role for RA on ILC2 maturation.
We next postulated that some effects of RA may result from a direct action on mature ILCs. Highly purified ILC2s exposed to RA or ILC3s treated with RAi for several days maintained their phenotype; therefore, we argue against an interconversion of these two populations (fig. S10, A to D). As previously reported, RA directly increased IL-22 (20) and RORgt expression by mature ILC3s and promoted ILC3 accumulation (fig. S11, A to D). Conversely, RA had a negative impact on ILC2 fitness, whereas treatment with RAi increased their proliferation, numbers, and IL-13 production in both mouse (fig. S12, A to C) and human cells ( fig. S13 ).
We next explored the possibility that vitamin A deficiency may tune the responsiveness of ILC2s to factors contributing to their survival or proliferation (11, 12) . Using mice deficient in IL-25, thymic stromal lymphopoietin (TSLP), or IL-33 receptors allowed us to exclude a dominant role for these factors (figs. S14 and S15). Of note, expression of the IL-7Ra, required for ILC development and survival (11, 12) , was reduced on ILC2s and ILC2Ps in the presence of RA, whereas the absence of RA signaling increased IL-7Ra expression by murine ILC2s and ILC2Ps, as well as human ILC2s (fig. S16, A to E). Increased IL7Ra expression conferred enhanced signaling capacity in response to IL-7 as measured by increased signal transducer and activator of transcription 5 (STAT5) (Fig. 2, J to L, and fig. S17 ). Together these results demonstrate that vitamin A deficiency is associated with altered ILC homeostasis and, in particular, increased IL-13-producing ILC2s, an effect potentially mediated by increased IL-7 responsiveness.
A corollary of our findings is that differential levels of vitamin A could promote different classes of barrier immunity with physiological levels of vitamin A associated with functional ILC3 responses, whereas reduced levels were associated with enhanced innate type 2 immunity. Indeed, both WT VAI mice and mice treated with RAi displayed enhanced susceptibility and pathology to Citrobacter rodentium compared with control mice (Fig. 3, A and B) , a phenotype associated with impaired T H 17 and ILC3 responses (Fig. 3, C and D, and fig. S18 , A to E). Treatment with RAi of Rag1 -/-mice, in which ILCs are the dominant source of IL-22 (21), dramatically increased pathology and mortality after infection (Fig. 3 , E to I), an effect reversed by exogenous delivery of IL-22 (Fig. 3, J (22, 23) .
Our results, thus far, predict that although T H 1, T H 17, and ILC3 collapse under vitamin A deficiency, type 2 immunity might be paradoxically augmented via an enhanced ILC2 response. In support of this, withdrawal of vitamin A heightened mucus production (15) . Goblet cells play a central role in barrier protection by the secretion of mucus and antimicrobial peptides (24) . Consistent with increased ILC2s observed in the absence of vitamin A, VAI Rag1 -/-mice displayed significant goblet cell hyperplasia and increased goblet cell-associated expression of the RELM-b gene, Retnlb, an effect largely dependent upon IL-13 (Fig. 4, A, B, and C) . In these settings, IL-13 production was predominantly ILC2-derived ( fig. S19 ). We next addressed whether enhanced ILC2 responses could compensate for the defect in T H 2 immunity during vitamin A deficiency (25) (26) (27) (28) (29) . To this end, we used a high dose of Trichuris muris eggs associated with T H 2 induction (30) . Although blocking RA impaired T H 2 induction, ILC2 numbers were significantly increased compared with those in infected control mice ( fig. S20, A and B) . Remarkably, RAitreated mice controlled parasite burden comparably to control mice, which supports the idea that ILC2s sustained worm control ( fig. S20C) . Further, both VAI and RAi-treated mice showed enhanced protection to physiological low-dose T. muris, a response associated with significant increase in the numbers of ILC2s and IL-13-producing ILCs (Fig. 4, D to H and fig. S21, A and  B) . In agreement with the role of IL-13 in T. muris control (31), accelerated worm clearance was critically dependent on this cytokine (Fig. 4G) . We next assessed the role of ILC2s in mediating worm expulsion independently of adaptive immunity. Remarkably, VAI Rag1 -/-mice displayed enhanced protection and reduced worm burden associated with substantial increase in ILC2 numbers and IL-13 production (Fig. 4, H, I , and J). Thus, vitamin A insufficiency leads to sustained and, in some cases, augmented control of nematode infection via the promotion of ILC2-dependent type 2 immunity. Our work suggests that vitamin A and its metabolite RA function together as a dietary alarm signal that allows the host to immunologically respond to its nutritional state. Contrary to the current paradigm, we show that nutrient deficiency is not associated with global immunosuppression but rather can selectively activate a distinct arm of barrier immunity. Notably, we found that ILC2s act as primary sensors of dietary stress able to compensate for the collapse of adaptive immunity in settings of nutrient deprivation. Type 2 immunity and, in particular, IL-13 are associated with tissue repair, increased mucus production, and physiological responses all aimed at reinforcing barrier integrity and defense (32, 33) . Furthermore, enhanced type 2 responses are clearly beneficial in the context of exposure to worms that have been partners throughout human evolution and still represent the major form of parasitic infection worldwide. Because nematodes compete with the host for nutritional resources, reinforcement of antihelminth immunity can also provide a substantial advantage to the host. Thus, in settings of malnutrition, a rapid switch to type 2 barrier immunity imposed by vitamin A deficiency may represent a powerful adaptation of the immune system to transiently promote host survival in the face of dominant barrier exposures.
Such a strategy leaves the host vulnerable to potential encounters with acute diarrheal pathogens but could provide a survival strategy to temporarily reduce the pressure from its constitutive evolutionary partners, worms and commensals, in settings of nutritional deprivation. The data presented in this manuscript are tabulated in the main paper and the supplementary materials.
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Figs. S1 to S22 Canine transmissible venereal tumor (CTVT) is the oldest known somatic cell lineage. It is a transmissible cancer that propagates naturally in dogs. We sequenced the genomes of two CTVT tumors and found that CTVT has acquired 1.9 million somatic substitution mutations and bears evidence of exposure to ultraviolet light. CTVT is remarkably stable and lacks subclonal heterogeneity despite thousands of rearrangements, copy-number changes, and retrotransposon insertions. More than 10,000 genes carry nonsynonymous variants, and 646 genes have been lost. CTVT first arose in a dog with low genomic heterozygosity that may have lived about 11,000 years ago. The cancer spawned by this individual dispersed across continents about 500 years ago. Our results provide a genetic identikit of an ancient dog and demonstrate the robustness of mammalian somatic cells to survive for millennia despite a massive mutation burden.
C anine transmissible venereal tumor (CTVT)
is a naturally occurring transmissible cancer. It is a clonal cell lineage that spreads within the domestic dog population by the allogeneic transfer of living cancer cells, usually during coitus. The disease manifests itself with the appearance of tumors most often associated with the external genitalia of male and female dogs. The first known report of CTVT was made in 1810, when it was described by a London veterinary practitioner as "an ulcerous state, accompanied with a fungous excrescence" that arises in "organs concerned in generation" (1) . It has subsequently been reported in dog populations worldwide (2, 3) and is, to our knowledge, the oldest and most widely disseminated cancer in the natural world.
We sequenced the genomes of two CTVT tumors, collected in Maningrida, Australia (24T), and Franca, Brazil (79T), as well as the genomes of their respective hosts 24H, an Aboriginal camp dog, and 79H, an American cocker spaniel (Fig. 1A) . We also prepared metaphases for cytogenetic analysis from two CTVTs collected in Cape Verde and Italy. Metaphase fluorescence in situ hybridization (FISH) using red fox chromosomes as probes revealed massive karyotypic rearrangement in the CTVT genome, which was highly consistent between the two tumors analyzed (Fig. 1B) . Despite the aneuploidy in CTVT detected by using cytogenetics, a copy-number analysis revealed that the genome is largely diploid [including a large proportion of the genome that is diploid with loss of heterozygosity (LOH)] and that there has been minimal change in copynumber status in 24T and 79T lineages since their divergence (Fig. 1C and tables S1 and S2) . In contrast to human tumors, most of which contain several detectable subclones (4), presumably because of positive selection for newly acquired mutations conferring selective advantage (5), we found no evidence for subclonality in CTVT metaphases or copy-number plots. This suggests that CTVT is not undergoing positive selection at high frequency, possibly indicating that it is well adapted to its niche.
CTVT's massive burden of karyotypic abnormalities despite its largely diploid genomic copy number indicates that the genome has undergone large-scale copy neutral structural rearrangement. We found 2118 candidate somatic structural variants that were shared between 24T and 79T and 216 and 72 candidate somatic structural variants in 24T and 79T, respectively, that were unique to one tumor. We also searched for evidence of transposon mobilization in CTVT. We found 348 and 352 transposon insertions (involving both long interspersed nuclear elements and short interspersed nuclear elements) that were unique to 24T and 79T, respectively, and are thus likely to represent somatic retrotransposition events that occurred after the divergence of 24T and 79T.
We identified 3.04 million substitution variants in 24T and 2.77 million in 79T after removing all single-nucleotide polymorphisms (SNPs) known to segregate in the dog or the wolf germ line (including those identified in 24H or 79H). These variants will include somatic mutations as well as SNPs that have not been captured in previous canine sequencing efforts. We estimated the true number of somatic substitution mutations in CTVT by calculating the ratio of homozygous to heterozygous known SNPs in diploid regions that retain both parental chromosomes. Assuming that all homozygous variants in these regions are SNPs, we were able to estimate the number of unannotated heterozygous SNPs in each diploid segment by using the homozygous-to-heterozygous ratio among annotated SNPs. This analysis indicated that at least 65% of unannotated variants in CTVT are likely to be somatic, corresponding to a total of 1.9 million somatic mutations in CTVT. A total of 103,667 and 109,119 variants were unique to 24T and 79T, respectively, the majority of which probably arose as somatic mutations after the two tumors' divergence because only 2056 and 5647, respectively, of these occur in regions that have been lost in the other tumor. Although a range of total mutation counts is observed in human cancers, the majority have between 1000 and 5000 somatic single-base-substitution mutations (6) . Thus, CTVT has acquired several hundred times more somatic mutations than most human cancers.
To ascertain the processes responsible for the mutations in CTVT, we characterized CTVT's mutational spectrum and searched for known mutational signatures (6) in the CTVT genomes. The CTVT mutation spectrum was dominated by C>T (or G>A) mutations and CC>TT (or GG>AA) dinucleotide mutations (Fig. 2, A and  B) . Four mutational signatures were identified in CTVT (labeled A to D, Fig. 2C ), which were sufficient to explain 98% of the mutations in CTVT (0.96 Pearson correlation between the mutation set observed in CTVT and the mutation set reconstructed by using four mutational signatures). The chemical events associated with some of these mutational signatures have been
